BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 38164270)

  • 21. Outdoor sports and skin cancer.
    Moehrle M
    Clin Dermatol; 2008; 26(1):12-5. PubMed ID: 18280899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC).
    Alves-Fernandes DK; Oliveira ÉA; Faião-Flores F; Alicea-Rebecca G; Weeraratna AT; Smalley KSM; Barros SBM; Maria-Engler SS
    Pharmacol Res; 2019 Mar; 141():63-72. PubMed ID: 30550954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma.
    Cybulska-Stopa B; Rogala P; Czarnecka AM; Galus Ł; Dziura R; Rajczykowski M; Kubiatowski T; Wiśniewska M; Gęga-Czarnota A; Teterycz P; Ziobro M; Suwiński R; Mackiewicz J; Rutkowski P
    Melanoma Res; 2020 Oct; 30(5):465-471. PubMed ID: 32221131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.
    Morgese F; Cognigni V; Scortichini L; Ranallo N; Lunerti V; Migliore A; Tronconi F; Berardi R
    Mol Clin Oncol; 2023 Jan; 18(1):2. PubMed ID: 36545211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CONSENSUS REPORT: Recognizing non-melanoma skin cancer, including actinic keratosis, as an occupational disease - A Call to Action.
    John SM; Trakatelli M; Gehring R; Finlay K; Fionda C; Wittlich M; Augustin M; Hilpert G; Barroso Dias JM; Ulrich C; Pellacani G
    J Eur Acad Dermatol Venereol; 2016 Apr; 30 Suppl 3():38-45. PubMed ID: 26995022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.
    Cucci MA; Grattarola M; Monge C; Roetto A; Barrera G; Caputo E; Dianzani C; Pizzimenti S
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37372043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined exercise intervention in a mouse model of high-risk neuroblastoma: effects on physical, immune, tumor and clinical outcomes.
    Rincón-Castanedo C; Martín-Ruiz A; Zazo S; Luis Huertas AL; Valenzuela PL; Morán M; Fleck SJ; Santos-Lozano A; Ramírez M; Rojo F; Lucia A; González-Murillo Á; Fiuza-Luces C
    Exerc Immunol Rev; 2023; 29():86-110. PubMed ID: 37358366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
    Oliveira ÉA; Chauhan J; Silva JRD; Carvalho LADC; Dias D; Carvalho DG; Watanabe LRM; Rebecca VW; Mills G; Lu Y; da Silva ASF; Consolaro MEL; Herlyn M; Possik PA; Goding CR; Maria-Engler SS
    Pharmacol Res; 2021 Nov; 173():105911. PubMed ID: 34560251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006.
    Long GV; Arance A; Mortier L; Lorigan P; Blank C; Mohr P; Schachter J; Grob JJ; Lotem M; Middleton MR; Neyns B; Steven N; Ribas A; Walpole E; Carlino MS; Lebbe C; Sznol M; Jensen E; Leiby MA; Ibrahim N; Robert C
    Ann Oncol; 2022 Feb; 33(2):204-215. PubMed ID: 34710571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between physical activity, grip strength and sedentary behaviour with incidence of malignant melanoma: results from the UK Biobank.
    Weber A; Leitzmann MF; Sedlmeier AM; Baurecht H; Jochem C; Haferkamp S; Baumeister SE
    Br J Cancer; 2021 Aug; 125(4):593-600. PubMed ID: 34059803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-Time UV Measurement With a Sun Protection System for Warning Young Adults About Sunburn: Prospective Cohort Study.
    Robinson JK; Patel S; Heo SY; Gray E; Lim J; Kwon K; Christiansen Z; Model J; Trueb J; Banks A; Kwasny M; Rogers JA
    JMIR Mhealth Uhealth; 2021 May; 9(5):e25895. PubMed ID: 33955844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Workplace exposure to UV radiation and strategies to minimize cancer risk.
    Cherrie JW; Cherrie MPC
    Br Med Bull; 2022 Dec; 144(1):45-56. PubMed ID: 35973164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerobic physical exercise for adult patients with haematological malignancies.
    Knips L; Bergenthal N; Streckmann F; Monsef I; Elter T; Skoetz N
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009075. PubMed ID: 30702150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis.
    Regnaux JP; Lefevre-Colau MM; Trinquart L; Nguyen C; Boutron I; Brosseau L; Ravaud P
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010203. PubMed ID: 26513223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round?
    Kadekaro AL; Kavanagh RJ; Wakamatsu K; Ito S; Pipitone MA; Abdel-Malek ZA
    Pigment Cell Res; 2003 Oct; 16(5):434-47. PubMed ID: 12950718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF
    Czarnecka AM; Ostaszewski K; Borkowska A; Szumera-Ciećkiewicz A; Kozak K; Świtaj T; Rogala P; Kalinowska I; Koseła-Paterczyk H; Zaborowski K; Teterycz P; Tysarowski A; Makuła D; Rutkowski P
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008274
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.